Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	45.82	10.52	7.21
Graham Fair Price	38.94	72960.00	52511.45
PEG	-73.27	0.05	-0.20
Price/Book	15.67	0.67	0.58
Price/Cash Flow	555.78	63.93	9.75
Prices/Earnings	-35.80	4.65	7.24
Price/Sales	25.63	3.11	2.48
Price/FCF	555.78	63.93	9.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.41	0.35	0.40
Operating Margin	-15.04	0.19	0.22
ROA	78.35	0.03	0.01
ROE	0.02	0.04	80.17
ROIC	0.02	0.03	22.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	-0.12	-47.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.24	-0.19	-21.43
EPS QOQ	-0.36	0.86	140.23
FCF QOQ	0.31	-0.82	164.88
Revenue QOQ	-0.05	-0.05	-1.68
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	135.03	137.46	1.79
Days Sales Outstanding (DSO)	75.72	84.63	11.77
Inventory Turnover	0.67	0.65	-1.76
Debt/Capitalization	0.08	0.08	1.00
Quick Ratio	2.03	1.87	-8.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	78306.47	81057.51	3.51
Cash	22619.07	23817.45	5.30
Capex	-1482.84	-1955.27	-31.86
Free Cash Flow	4651.81	849.35	-81.74
Revenue	18297.01	17438.16	-4.69
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.96	2.71	-8.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.74	-2.18	-25.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating